Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes.

Authors :: Egeberg A
Merola JF
Schäkel K
Puig L
Mahar PD
Wang IY
Pavo I
Schuster C
Griffiths CEM
Source :: Frontiers in medicine [Front Med (Lausanne)] 2023 Mar 10; Vol. 10, pp. 1171132. Date of Electronic Publication: 2023 Mar 10 (Print Publication: 2023).
Publication Year :: 2023
Abstract: [This corrects the article DOI: 10.3389/fmed.2022.1092688.].<br /> (Copyright © 2023 Egeberg, Merola, Schäkel, Puig, Mahar, Wang, Pavo, Schuster and Griffiths.)

Full Text Access

Tools